# US 2024/0189558 A1 · Devices, systems, and methods for delivering topical medication

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189558 A1
- Document ID: US20240189558A1
- Status: Published application
- Kind: A1
- Application number: 18/078,440
- Filed: 2022-12-09
- Published: 2024-06-13
- Earliest claimed: 2022-12-09
- Inventors: Daniel J. GOULD
- Web page: https://patentgrep.com/patent/US20240189558A1

## CPC

- A61M 35/003: {Portable hand-held applicators having means for dispensing or spreading integral media (hand-held massage devices with liquid delivery A61H7/003)}
- A61M 2205/586: Ergonomic details therefor, e.g. specific ergonomics for left or right-handed users
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Disclosed herein are devices, systems, and methods for applying and/or delivering topical compounds to the surface of a tissue. Specifically, disclosed embodiments include a device that is configured to connect to a variety of syringes and syringe tips. At least one embodiment of the device comprises a cap and a membrane, where the cap includes an open connector end for engaging and/or attaching to a syringe via a syringe tip. A delivery end is disposed opposite to the connector end. A cap body is disposed between, and connecting, the connector end and the delivery end. The delivery end may be operably connected to the membrane by inserting one end of the membrane into the delivery end. In use, the disclosed devices benefit from unique control and even application of the medicines disposed therein.

## Claims

### Claim 1

A device for delivering one or more topical compounds to a surface of mammalian tissue, the device comprising:
a hollow portion comprising:
a first end,
a second end disposed opposite the first end, and
a body disposed between, and connecting, the first end and the second end;
a membrane comprising:
an open end,
a closed end opposite the open end, and
a neck disposed between, and connecting, the open end and the closed end;
wherein the open end is fluidly connected to the second end, and
wherein the first end comprises a connector mechanism configured to releasably connect to a syringe tip such that the first end is fluidly connected to the syringe tip.

### Claim 2 (depends on 1)

The device of claim 1, wherein the membrane is selectively permeable to the one or more topical compounds.

### Claim 3 (depends on 1)

The device of claim 1, wherein the membrane comprises one or more synthetic polymers.

### Claim 4 (depends on 1)

The device of claim 1, wherein the connector mechanism comprises a luer-style connector.

### Claim 5 (depends on 1)

The device of claim 1, wherein the connector mechanism is selected from the group consisting of: a slip-on connection, a push-on connection, an eccentric tip, a tapered tip, a catheter tip, and combinations thereof.

### Claim 6 (depends on 1)

A method for delivering one or more topical compounds to a surface of human tissue, the method comprising:
filling the hollow portion of the device of claim 1 with the one or more topical compounds;
extruding at least one portion of the one or more topical compounds through the membrane; and
contacting the at least one portion of the one or more topical compounds to the surface of the human tissue.

### Claim 7

A device for delivering one or more topical compounds to a surface of human tissue, the device comprising:
a syringe comprising:
a barrel, and
a syringe tip fluidly connected to the barrel,
wherein the syringe tip comprises one or more openings;
a cap comprising:
an open connector end,
an open delivery end fluidly connected to the open connector end, and
a cap body disposed between, and connecting, the open connector end and the open delivery end,
wherein the open connector end is releasably connected to the syringe tip such that the one or more openings are fluidly connected to the cap;
a membrane comprising a delivery surface,
wherein the membrane is connected to the open delivery end such that the delivery surface closes the open delivery end, and
wherein the membrane is selectively permeable to the one or more topical compounds.

### Claim 8 (depends on 7)

The device of claim 7, wherein the releasable connection between the connector end and the syringe tip is provided by a luer-style connector.

### Claim 9 (depends on 7)

The device of claim 7, wherein the releasable connection between the connector end and the syringe tip is provided by a connection mechanism selected from the group consisting of: a slip-on connection, a push-on connection, an eccentric tip, a tapered tip, a catheter tip, and combinations thereof.

### Claim 10 (depends on 7)

The device of claim 7, wherein the cap is cylindrical in shape.

### Claim 11 (depends on 7)

The device of claim 7, wherein the membrane comprises one or more synthetic polymers.

### Claim 12 (depends on 7)

The device of claim 7, wherein the membrane is removable from the open delivery end.

### Claim 13 (depends on 7)

The device of claim 7, wherein the syringe is selected from the group consisting of: a disposable syringe, a safety syringe, an insulin syringe, a hypodermic syringe, a multi-shot needle syringe, a venom extraction syringe, an oral syringe, a dental syringe, a dose-sparing syringe, a glass syringe, a plastic syringe, and combinations thereof.

### Claim 14 (depends on 7)

The device of claim 7, wherein the one or more topical compounds is selected from the group consisting of: topical steroids, growth factors, anti-scarring medications, vitamins, anti-aging compounds, anti-inflammatory compounds, triamcinolone, fluorouracil, tranexamic acid, azelaic acid, bleaching agents, topical numbing agents, topical antibiotics, histological dyes, histological stains, topical skin darkening agents, botulinum toxin, hyaluronic acid, skincare compounds, cosmetic compounds, nutraceutical compounds, and combinations thereof.

### Claim 15 (depends on 7)

A method for delivering one or more topical compounds to a surface of human tissue, the method comprising:
moving the one or more topical compounds from the barrel of the syringe of claim 7 through the one or more openings in the syringe tip and into the cap;
moving at least one portion of the one or more topical compounds from the cap through the membrane;
applying the at least one portion of the one or more topical compounds to a surface of human tissue.

### Claim 16

A method for delivering one or more topical compounds to a surface of human tissue, the method comprising:
obtaining an applicator containing one or more topical compounds to be delivered, wherein the applicator comprises a cap and a membrane, wherein the cap comprises one end connected to the membrane, and wherein the cap comprises an inner area;
exerting force on the applicator to move the one or more topical compounds through the inner area and through the one end, such that at least one portion of the one or more topical compounds are extruded through the membrane; and
positioning the applicator adjacent to a surface of human tissue such that the at least one portion of the one or more topical compounds contacts the surface, thereby delivering the one or more topical compounds.

### Claim 17 (depends on 16)

The method of claim 16, wherein the applicator comprises a syringe, and wherein the syringe comprises a barrel and a syringe tip.

### Claim 18 (depends on 17)

The method of claim 17, wherein the cap comprises a connector end configured to connect to the syringe tip.

### Claim 19 (depends on 17)

The method of claim 17, further comprising:
engaging the membrane with the one end of the cap, and/or
engaging a connector end of the cap with the syringe tip.

### Claim 20 (depends on 18)

The method of claim 18, wherein the exerting force on the applicator further comprises:
exerting the force on the barrel of the syringe, thereby moving the one or more topical compounds through the syringe tip and through the connector end.

### Claim 21 (depends on 16)

The method of claim 16, wherein the exerting force on the applicator further comprises:
holding the applicator between a thumb and at least one finger of one hand.
